Page last updated: 2024-10-25

cimetidine and Orbital Diseases

cimetidine has been researched along with Orbital Diseases in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Orbital Diseases: Diseases of the bony orbit and contents except the eyeball.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zborowski-Gutman, L1
Gutman, I1
Chen, V1
Sharir, M1
Findler, G1
Jacoby, BG1
Wesley, RE1

Other Studies

2 other studies available for cimetidine and Orbital Diseases

ArticleYear
Acute angle closure glaucoma precipitated by orbital pseudotumour.
    The British journal of ophthalmology, 1988, Volume: 72, Issue:2

    Topics: Cimetidine; Drug Therapy, Combination; Female; Glaucoma; Humans; Middle Aged; Orbital Diseases; Pred

1988
Painful orbital inflammatory lesions and mastocytosis.
    Annals of ophthalmology, 1987, Volume: 19, Issue:4

    Topics: Adolescent; Biopsy; Cimetidine; Clemastine; Combined Modality Therapy; Diphenhydramine; Drug Therapy

1987